Publicacions
-
Benitez-Ribas D, Cabezón R, Flórez-Grau G, Molero MC, Puerta P, Guillen-Quesada A, Paco-Mercader S, Carcaboso AM, Santa-Maria Lopez V, Cruz-Martínez O, de Torres C, Salvador N, Juan M, Mora J and Morales-La Madrid A.
Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Frontiers in oncology . 8: 127-127. Nº de cites: 31
-
Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND, Neftel C, Frank N, Pelton K, Hebert CM, Haberler C, Yizhak K, Gojo J, Egervari K, Mount C, van Galen P, Bonal DM, Nguyen QD, Beck A, Sinai C, Czech T, Dorfer C, Goumnerova L, Lavarino C, Carcaboso AM, Mora J, Mylvaganam R, Luo CC, Peyrl A, Popovic M, Azizi A, Batchelor TT, Frosch MP, Martinez-Lage M, Kieran MW, Bandopadhayay P, Beroukhim R, Fritsch G, Getz G, Rozenblatt-Rosen O, Wucherpfennig KW, Louis DN, Monje M, Slavc I, Ligon KL, Golub TR, Regev A, Bernstein BE and Suvà ML.
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq
SCIENCE . 360(6386): 331-335. Nº de cites: 415
-
Royer-Pokora B, Beier M, Brandt A, Duhme C, Busch M, de Torres C, Royer HD and Mora J.
Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors
CANCER MEDICINE . 7(4): 1359-1368. Nº de cites: 9
-
Mora J, Pérez-Jaume S and Cruz-Martínez O.
Treatment of childhood astrocytomas with irinotecan and cisplatin
CLINICAL & TRANSLATIONAL ONCOLOGY . 20(4): 500-507. Nº de cites: 3
-
Gomez-Gonzalez S, Garrido- García A, García-Gerique L, Lemos I, Suñol M, de Torres C, Kulis M, Pérez-Jaume S, Carcaboso AM, Luu B, Kieran MW, Jabado N, Kozlenkov A, Dracheva S, Ramaswamy V, Hovestadt V, Johann P, Jones DTW, Pfister SM, Morales-La Madrid A, Cruz-Martínez O, Taylor MD, Martín-Subero JI, Mora J and Lavarino C.
A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma
CLINICAL CANCER RESEARCH . 24(6): 1355-1363. Nº de cites: 22
-
Prieto C, López-Millán B, Roca-Ho H, Stam RW, Romero-Moya D, Rodríguez-Baena FJ, Sanjuan-Pla A, Ayllón V, Ramírez M, Bardini M, De Lorenzo P, Valsecchi MG, Stanulla M, Iglesias M, Ballerini P, Carcaboso AM, Mora J, Locatelli F, Bertaina A, Padilla L, Rodríguez-Manzaneque JC, Bueno C and Menéndez P.
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL
Leukemia . 32(3): 633-644. Nº de cites: 29
-
Iniguez AB, Stolte B, Wang EJ, Conway AS, Alexe G, Dharia NV, Kwiatkowski N, Zhang T, Abraham BJ, Mora J, Kalev P, Leggett A, Chowdhury D, Benes CH, Young RA, Gray NS and Stegmaier K.
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma
Cancer Cell . 33(2): 202-216. Nº de cites: 115
-
Krauel L, De Haro-Jorge I, Carrasco-Torrents R, Vancells M and Mora J.
Upfront Nephrectomy for the Treatment of Wilms Tumor: Outcomes and Predictors of Complications
Journal of Child Science . 8: 21-26.
-
Ding YY, Panzer J, Maris JM, Castañeda-Heredia A, Gómez-Chiari M and Mora J.
Transverse myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma: A case series
PEDIATRIC BLOOD & CANCER . 65(1): . Nº de cites: 19
-
Martin-Broto J, Redondo A, Valverde C, Vaz MA, Mora J, Garcia Del Muro X, Gutierrez A, Tous C, Carnero A, Marcilla D, Carranza A, Sancho P, Martinez-Trufero J, Diaz-Beveridge R, Cruz J, Encinas V, Taron M, Moura DS, Luna P, Hindi N and Lopez-Pousa A.
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)
ANNALS OF ONCOLOGY . 28(12): 2994-2999. Nº de cites: 48